Latest News

Grant Announcement: Cure SMA Awards $190,000 Grant to Stephen Meriney, Ph.D., University of Pittsburgh

April 17, 2020
Posted in ,

This article is the last in a series of Cure SMA grant announcements that have been shared throughout the past months. Cure SMA has awarded a $190,000 research grant to […]

Read More ›

Cure SMA Announces Cancellation of 2020 Annual SMA Conference and Research & Clinical Care Meeting

April 9, 2020
Posted in ,

Cure SMA has been closely monitoring news and reports of the Coronavirus (COVID-19) outbreak, allowing us to make decisions about local events and offer new resources that support the SMA […]

Read More ›

Community Statement from AveXis Regarding Commitment to SMA Community Amid COVID-19 Pandemic

April 8, 2020
Posted in ,

          Dear SMA Community, Like many organizations across the United States and around the world, AveXis is closely monitoring the coronavirus disease (COVID-19) and its impact […]

Read More ›

Community Statement from Genentech on Risdiplam Approval Timeline

April 7, 2020
Posted in ,

        Dear SMA Community, As part of our ongoing partnership and following your request to receive important information about the risdiplam clinical development program, we wanted to […]

Read More ›

Answering Your Coronavirus (COVID-19) Medical Questions

April 2, 2020
Posted in

We want you to know that Cure SMA continues to be here for the entire SMA community. We remain vigilant in monitoring and responding to your needs, as your health, […]

Read More ›

Biogen Announces First Patient Treated With Higher Dose Of Spinraza In Phase 2/3 DEVOTE Study

April 2, 2020
Posted in ,

Biogen today announced that the first patient has been treated in the global clinical study, DEVOTE. The study is designed to evaluate the safety, tolerability, and potential for even greater […]

Read More ›
Scroll to Top